study therapy

study therapy

The type of therapy used in a clinical trial.
Mentioned in ?
References in periodicals archive ?
A sensitivity analysis, including 54 patients who received at least four cycles of study therapy (pracinostat or placebo) and azacitidine showed a trend for better progression-free survival and overall survival (hazard ratio = 0.
The company said that the reported Phase II SAPHIRE trial for resminostat as a third-line therapy in Hodgkin's lymphoma is still ongoing as two patients are continuing on study therapy in the optional follow-up phase beyond 12 weeks of treatment.
The incidence of the adverse events declined markedly after 2-4 weeks of study therapy.
Our study therapy of active Crohn's disease with Boswellia serrata extract H15 [Z.
Compliance with study therapy and tolerability were comparable in the 3 treatment groups.
Fourteen patients were excluded from the final analysis for the following reasons: absence of photographic confirmation of CMV retinitis at study entry (5); noncompliance with study therapy (4); absence of efficacy data reported after randomization (3); presence of a ganciclovir implant in one eye (1); and no receipt of any doses of study drug (1).
HCFA is to study therapy services and report to Congress on establishment of an alternative payment policy.
SAEs in Groups A1 and A2 included panic attack, forearm fracture, viral gastroenteritis, and prostate cancer; all were determined by study investigators to be unrelated to study therapy.
An additional analysis evaluated the reinfection incidence among all patients who completed active study therapy (n=296).
Patients who are tolerating primary study therapy (GS-1101 or placebo) will be eligible to receive active GS-1101 therapy in a double-blind extension study (Study 117).
The reported Phase II SAPHIRE trial for resminostat as a third-line therapy in Hodgkin's lymphoma is still ongoing as patients are continuing on study therapy in the optional follow-up phase beyond the study's main treatment cycle of 12 weeks.
Additional two patients are currently continuing on study therapy in the optional follow-up phase, and have therefore not been subject to final response evaluation by the independent review board.

Full browser ?